CN102482305B - N4-(2,2-二甲基-4-[(二氢膦酰氧基)甲基]-3-氧代-5-吡啶并[1,4]噁嗪-6-基)-5-氟-n2-(3,4,5-三甲氧基苯基)-2,4-嘧啶二胺二钠盐的合成 - Google Patents
N4-(2,2-二甲基-4-[(二氢膦酰氧基)甲基]-3-氧代-5-吡啶并[1,4]噁嗪-6-基)-5-氟-n2-(3,4,5-三甲氧基苯基)-2,4-嘧啶二胺二钠盐的合成 Download PDFInfo
- Publication number
- CN102482305B CN102482305B CN201080039108.1A CN201080039108A CN102482305B CN 102482305 B CN102482305 B CN 102482305B CN 201080039108 A CN201080039108 A CN 201080039108A CN 102482305 B CN102482305 B CN 102482305B
- Authority
- CN
- China
- Prior art keywords
- formula
- compound
- amide
- solvate
- tert
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- GKDRMWXFWHEQQT-UHFFFAOYSA-N CC(C)(C(N1COP(O)(O)=O)=O)Oc(cc2)c1nc2Nc(nc(Nc(cc1OC)cc(OC)c1OC)nc1)c1F Chemical compound CC(C)(C(N1COP(O)(O)=O)=O)Oc(cc2)c1nc2Nc(nc(Nc(cc1OC)cc(OC)c1OC)nc1)c1F GKDRMWXFWHEQQT-UHFFFAOYSA-N 0.000 description 2
- LNXIKEOPYQNZKM-UHFFFAOYSA-N CC(C)(C)OP(OCN1c(nc(cc2)Nc(nc(Nc(cc3OC)cc(OC)c3OC)nc3)c3F)c2OC(C)(C)C1=O)(OC(C)(C)C)=O Chemical compound CC(C)(C)OP(OCN1c(nc(cc2)Nc(nc(Nc(cc3OC)cc(OC)c3OC)nc3)c3F)c2OC(C)(C)C1=O)(OC(C)(C)C)=O LNXIKEOPYQNZKM-UHFFFAOYSA-N 0.000 description 1
- NHHQJBCNYHBUSI-UHFFFAOYSA-N CC1(C)Oc2ccc(Nc(nc(Nc(cc3OC)cc(OC)c3OC)nc3)c3F)nc2NC1=O Chemical compound CC1(C)Oc2ccc(Nc(nc(Nc(cc3OC)cc(OC)c3OC)nc3)c3F)nc2NC1=O NHHQJBCNYHBUSI-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27007309P | 2009-07-02 | 2009-07-02 | |
| US61/270,073 | 2009-07-02 | ||
| PCT/US2010/040792 WO2011002999A1 (en) | 2009-07-02 | 2010-07-01 | Synthesis of n4- (2, 2-dimethyl-4- [ (dihydrogen phosphonoxy ] -3-oxo-5-pyrido [1, 4] oxazin-6-yl)-5-fluoro-n2- (3, 4, 5,-trimethoxyphenyl) -2, 4- pyrimidinediamine disodium salt |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102482305A CN102482305A (zh) | 2012-05-30 |
| CN102482305B true CN102482305B (zh) | 2016-07-13 |
Family
ID=42937685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201080039108.1A Active CN102482305B (zh) | 2009-07-02 | 2010-07-01 | N4-(2,2-二甲基-4-[(二氢膦酰氧基)甲基]-3-氧代-5-吡啶并[1,4]噁嗪-6-基)-5-氟-n2-(3,4,5-三甲氧基苯基)-2,4-嘧啶二胺二钠盐的合成 |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US8299242B2 (enExample) |
| EP (1) | EP2448950B1 (enExample) |
| JP (1) | JP5739882B2 (enExample) |
| CN (1) | CN102482305B (enExample) |
| AU (1) | AU2010266213B2 (enExample) |
| BR (1) | BRPI1011888A2 (enExample) |
| CA (1) | CA2766801C (enExample) |
| CY (1) | CY1117489T1 (enExample) |
| DK (1) | DK2448950T3 (enExample) |
| EA (1) | EA021657B1 (enExample) |
| ES (1) | ES2565985T3 (enExample) |
| HR (1) | HRP20160319T1 (enExample) |
| HU (1) | HUE027212T2 (enExample) |
| ME (1) | ME02388B (enExample) |
| PL (1) | PL2448950T3 (enExample) |
| RS (1) | RS54679B1 (enExample) |
| SG (1) | SG176799A1 (enExample) |
| SI (1) | SI2448950T1 (enExample) |
| SM (1) | SMT201600084B (enExample) |
| UA (1) | UA108077C2 (enExample) |
| WO (1) | WO2011002999A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5468899B2 (ja) | 2006-07-20 | 2014-04-09 | アフィニウム ファーマシューティカルズ， インク． | Ｆａｂｉインヒビターとしてのアクリルアミド誘導体 |
| UA108077C2 (xx) | 2009-07-02 | 2015-03-25 | Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну | |
| US20110206661A1 (en) * | 2010-02-24 | 2011-08-25 | Auspex Pharmaceuticals, Inc. | Trimethoxyphenyl inhibitors of tyrosine kinase |
| EP2736487B2 (en) * | 2011-07-28 | 2024-08-28 | Rigel Pharmaceuticals, Inc. | New (trimethoxyphenylamino)pyrimidinyl formulations |
| TWI526437B (zh) * | 2011-09-09 | 2016-03-21 | 台灣神隆股份有限公司 | 卡巴他賽之結晶型 |
| US8426450B1 (en) * | 2011-11-29 | 2013-04-23 | Helsinn Healthcare Sa | Substituted 4-phenyl pyridines having anti-emetic effect |
| MY170437A (en) | 2012-06-19 | 2019-07-31 | Debiopharm Int Sa | Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
| CN102746337B (zh) * | 2012-06-21 | 2014-12-17 | 成都苑东药业有限公司 | 一种2，4-嘧啶二胺类化合物及其制备方法 |
| TW201410657A (zh) | 2012-08-02 | 2014-03-16 | Endo Pharmaceuticals Inc | 經取代胺基－嘧啶衍生物 |
| LT3083648T (lt) * | 2013-12-20 | 2019-01-25 | Rigel Pharmaceuticals, Inc. | Farmacinis būdas ir tarpiniai junginiai |
| PL3419628T3 (pl) | 2016-02-26 | 2021-05-31 | Debiopharm International Sa | Lek do leczenia zakażeń stopy cukrzycowej |
| EP3509578B1 (en) | 2016-09-08 | 2022-12-21 | Glykon Technologies Group, LLC | Monomeric bimetal hydroxycitric acid compounds and methods of making and using the same |
| JP2020536100A (ja) * | 2017-10-04 | 2020-12-10 | セルジーン コーポレイション | シス−４−［２−｛［（３ｓ，４ｒ）−３−フルオロキサン−４−イル］アミノ｝−８−（２，４，６−トリクロロアニリノ）−９ｈ−プリン−９−イル］−１−メチルシクロヘキサン−１−カルボキサミドの製造プロセス |
| HRP20230437T1 (hr) | 2019-02-14 | 2023-07-07 | Debiopharm International S.A. | Formulacija afabicina, postupak izrade iste |
| CN113939306B (zh) | 2019-06-14 | 2024-07-19 | 德彪药业国际股份公司 | 用于治疗涉及生物膜的细菌感染的药物及其用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US303022A (en) | 1884-08-05 | Egg-beater | ||
| US324087A (en) | 1885-08-11 | Abel combs | ||
| TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
| US20040024716A1 (en) | 2002-04-12 | 2004-02-05 | James Malatesta | Mail sorting processes and systems |
| CN103169708B (zh) | 2002-07-29 | 2018-02-02 | 里格尔药品股份有限公司 | 用2,4‑嘧啶二胺化合物治疗或者预防自体免疫性疾病的方法 |
| US7122542B2 (en) | 2003-07-30 | 2006-10-17 | Rigel Pharmaceuticals, Inc. | Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| US20060047135A1 (en) | 2004-08-30 | 2006-03-02 | Chadwick Scott T | Process for preparing chloromethyl di-tert-butylphosphate |
| US7449458B2 (en) * | 2005-01-19 | 2008-11-11 | Rigel Pharmaceuticals, Inc. | Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| US20090114877A1 (en) * | 2005-09-13 | 2009-05-07 | Eisai R&D Management Co., Ltd. | Composition Containing Stability-Improved Chloromethyl Phosphate Derivatve and Process for Producing Same |
| US8163902B2 (en) * | 2006-11-21 | 2012-04-24 | Rigel Pharmaceuticals, Inc. | Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| UA108077C2 (xx) | 2009-07-02 | 2015-03-25 | Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну |
-
2010
- 2010-01-07 UA UAA201201072A patent/UA108077C2/ru unknown
- 2010-07-01 EP EP10730679.7A patent/EP2448950B1/en active Active
- 2010-07-01 PL PL10730679T patent/PL2448950T3/pl unknown
- 2010-07-01 HR HRP20160319TT patent/HRP20160319T1/hr unknown
- 2010-07-01 BR BRPI1011888A patent/BRPI1011888A2/pt not_active Application Discontinuation
- 2010-07-01 US US12/829,126 patent/US8299242B2/en active Active
- 2010-07-01 CN CN201080039108.1A patent/CN102482305B/zh active Active
- 2010-07-01 WO PCT/US2010/040792 patent/WO2011002999A1/en not_active Ceased
- 2010-07-01 HU HUE10730679A patent/HUE027212T2/en unknown
- 2010-07-01 DK DK10730679.7T patent/DK2448950T3/en active
- 2010-07-01 JP JP2012518607A patent/JP5739882B2/ja active Active
- 2010-07-01 AU AU2010266213A patent/AU2010266213B2/en active Active
- 2010-07-01 SG SG2011091733A patent/SG176799A1/en unknown
- 2010-07-01 SI SI201031148A patent/SI2448950T1/sl unknown
- 2010-07-01 RS RS20160220A patent/RS54679B1/sr unknown
- 2010-07-01 EA EA201270114A patent/EA021657B1/ru unknown
- 2010-07-01 ES ES10730679.7T patent/ES2565985T3/es active Active
- 2010-07-01 ME MEP-2016-57A patent/ME02388B/me unknown
- 2010-07-01 CA CA2766801A patent/CA2766801C/en active Active
-
2012
- 2012-09-24 US US13/625,552 patent/US8481724B2/en active Active
-
2013
- 2013-06-07 US US13/912,856 patent/US8691798B2/en active Active
-
2016
- 2016-03-24 SM SM201600084T patent/SMT201600084B/xx unknown
- 2016-04-12 CY CY20161100304T patent/CY1117489T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2766801C (en) | 2018-03-13 |
| US20110003986A1 (en) | 2011-01-06 |
| CN102482305A (zh) | 2012-05-30 |
| BRPI1011888A2 (pt) | 2016-04-12 |
| US20130274499A1 (en) | 2013-10-17 |
| HRP20160319T1 (hr) | 2016-04-22 |
| AU2010266213A1 (en) | 2012-02-02 |
| SI2448950T1 (sl) | 2016-05-31 |
| JP5739882B2 (ja) | 2015-06-24 |
| HUE027212T2 (en) | 2016-10-28 |
| RS54679B1 (sr) | 2016-08-31 |
| WO2011002999A1 (en) | 2011-01-06 |
| EP2448950A1 (en) | 2012-05-09 |
| AU2010266213B2 (en) | 2015-06-18 |
| CY1117489T1 (el) | 2017-04-26 |
| EP2448950B1 (en) | 2016-01-13 |
| DK2448950T3 (en) | 2016-04-04 |
| US8691798B2 (en) | 2014-04-08 |
| SMT201600084B (it) | 2016-04-29 |
| EA021657B1 (ru) | 2015-08-31 |
| US8481724B2 (en) | 2013-07-09 |
| CA2766801A1 (en) | 2011-01-06 |
| US8299242B2 (en) | 2012-10-30 |
| EA201270114A1 (ru) | 2012-05-30 |
| ME02388B (me) | 2016-09-20 |
| PL2448950T3 (pl) | 2016-06-30 |
| SG176799A1 (en) | 2012-01-30 |
| US20130018185A1 (en) | 2013-01-17 |
| UA108077C2 (xx) | 2015-03-25 |
| HK1169996A1 (zh) | 2013-02-15 |
| ES2565985T3 (es) | 2016-04-08 |
| JP2012532143A (ja) | 2012-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102482305B (zh) | N4-(2,2-二甲基-4-[(二氢膦酰氧基)甲基]-3-氧代-5-吡啶并[1,4]噁嗪-6-基)-5-氟-n2-(3,4,5-三甲氧基苯基)-2,4-嘧啶二胺二钠盐的合成 | |
| WO2023284537A1 (en) | Kras g12d inhibitors and uses thereof | |
| CN103200822B (zh) | 2-取代-8-烷基-7-氧代-7,8-二氢吡啶并[2,3-d]嘧啶-6-腈和其应用 | |
| DK2970263T3 (en) | PROCESSES FOR THE MANUFACTURE OF AN APOPTOSIS-PRACTICING EFFECT | |
| ES2605638T3 (es) | Proceso Mejorado para fabricar 5-(2,6-di-4-morfolinil-4-pirimidinil)-4-trifluorometilpiridin-2-amina | |
| WO2025045141A1 (en) | Kras inhibitors and uses thereof | |
| ES2607807T3 (es) | Procedimiento para la preparación de los inibidores de las quinasas c-fms | |
| US10196411B2 (en) | Tizoxanide phosphate and alkane sulfonate and pharmaceutical applications thereof | |
| JP5558492B2 (ja) | ロスバスタチンまたは医薬として許容されるこの塩の合成のための主要中間体 | |
| MXPA06014797A (es) | Procesos para preparacion de antagonistas de receptor de hormona que libera gonadotropina. | |
| CN105960394A (zh) | 二氢吲哚化合物的制造方法 | |
| CN105377848A (zh) | 取代的三唑并吡啶的前体药物衍生物 | |
| ES2433218T3 (es) | Fenil-alquil piperazinas que tienen una actividad moduladora de TNF | |
| CN108064222A (zh) | N-苯基-(吗啉-4-基或哌嗪基)乙酰胺衍生物及其作为wnt信号通路抑制剂的用途 | |
| HK1169996B (en) | Synthesis of n4- (2, 2-dimethyl-4- [(dihydrogen phosphonoxy)methyl]-3-oxo-5-pyrido [1, 4]oxazin-6-yl)-5-fluoro-n2- (3, 4, 5,-trimethoxyphenyl)-2, 4- pyrimidinediamine disodium salt | |
| TWI285643B (en) | A polymorph of 1-{6-ethoxy-5-[3-ethyl-6,7-dihydro-2-(2-methoxyethyl)-7-oxo-2H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-pyridylsulfonyl}-4-ethylpiperazine and a process for preparing the same | |
| JPWO2014034124A1 (ja) | 簡易製造法 | |
| HK1158630A (en) | Phenyl-alkyl piperazines having a modulating activity of tnf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |